These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17603162)
1. Identification of Y118 amino acid residue in Candida albicans sterol 14alpha-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues. Chen SH; Sheng CQ; Xu XH; Jiang YY; Zhang WN; He C Biol Pharm Bull; 2007 Jul; 30(7):1246-53. PubMed ID: 17603162 [TBL] [Abstract][Full Text] [Related]
2. Improved model of lanosterol 14alpha-demethylase by ligand-supported homology modeling: validation by virtual screening and azole optimization. Sheng C; Wang W; Che X; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W ChemMedChem; 2010 Mar; 5(3):390-7. PubMed ID: 20157915 [TBL] [Abstract][Full Text] [Related]
3. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Sanglard D; Ischer F; Koymans L; Bille J Antimicrob Agents Chemother; 1998 Feb; 42(2):241-53. PubMed ID: 9527767 [TBL] [Abstract][Full Text] [Related]
4. Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds. Kudo M; Ohi M; Aoyama Y; Nitahara Y; Chung SK; Yoshida Y J Biochem; 2005 May; 137(5):625-32. PubMed ID: 15944416 [TBL] [Abstract][Full Text] [Related]
5. The Evolution of Azole Resistance in Warrilow AG; Nishimoto AT; Parker JE; Price CL; Flowers SA; Kelly DE; Rogers PD; Kelly SL Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783005 [TBL] [Abstract][Full Text] [Related]
6. The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance. Alvarez-Rueda N; Fleury A; Logé C; Pagniez F; Robert E; Morio F; Le Pape P Med Mycol; 2016 Oct; 54(7):764-775. PubMed ID: 27143634 [TBL] [Abstract][Full Text] [Related]
7. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance. Wu Y; Gao N; Li C; Gao J; Ying C FEMS Yeast Res; 2017 May; 17(3):. PubMed ID: 28334124 [TBL] [Abstract][Full Text] [Related]
8. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Xiao L; Madison V; Chau AS; Loebenberg D; Palermo RE; McNicholas PM Antimicrob Agents Chemother; 2004 Feb; 48(2):568-74. PubMed ID: 14742211 [TBL] [Abstract][Full Text] [Related]
9. New azoles with potent antifungal activity: design, synthesis and molecular docking. Che X; Sheng C; Wang W; Cao Y; Xu Y; Ji H; Dong G; Miao Z; Yao J; Zhang W Eur J Med Chem; 2009 Oct; 44(10):4218-26. PubMed ID: 19539408 [TBL] [Abstract][Full Text] [Related]
10. Formation of azole-resistant Candida albicans by mutation of sterol 14-demethylase P450. Asai K; Tsuchimori N; Okonogi K; Perfect JR; Gotoh O; Yoshida Y Antimicrob Agents Chemother; 1999 May; 43(5):1163-9. PubMed ID: 10223930 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the combination mode of azoles antifungal inhibitors with CACYP51 and the influence of Site-directed mutation. Sun B; Huang W; Liu M J Mol Graph Model; 2017 May; 73():157-165. PubMed ID: 28282632 [TBL] [Abstract][Full Text] [Related]
12. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem. Kelly SL; Lamb DC; Kelly DE FEMS Microbiol Lett; 1999 Nov; 180(2):171-5. PubMed ID: 10556708 [TBL] [Abstract][Full Text] [Related]
13. Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei. Fukuoka T; Johnston DA; Winslow CA; de Groot MJ; Burt C; Hitchcock CA; Filler SG Antimicrob Agents Chemother; 2003 Apr; 47(4):1213-9. PubMed ID: 12654649 [TBL] [Abstract][Full Text] [Related]
14. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms. Sanglard D; Coste AT Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310 [TBL] [Abstract][Full Text] [Related]
15. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans. Favre B; Didmon M; Ryder NS Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193 [TBL] [Abstract][Full Text] [Related]
16. Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Marichal P; Koymans L; Willemsens S; Bellens D; Verhasselt P; Luyten W; Borgers M; Ramaekers FCS; Odds FC; Vanden Bossche H Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2701-2713. PubMed ID: 10537192 [TBL] [Abstract][Full Text] [Related]
17. Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Warrilow AG; Parker JE; Kelly DE; Kelly SL Antimicrob Agents Chemother; 2013 Mar; 57(3):1352-60. PubMed ID: 23274672 [TBL] [Abstract][Full Text] [Related]
18. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals. Ji H; Zhang W; Zhou Y; Zhang M; Zhu J; Song Y; Lü J J Med Chem; 2000 Jun; 43(13):2493-505. PubMed ID: 10891108 [TBL] [Abstract][Full Text] [Related]
19. S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole. Warrilow AG; Mullins JG; Hull CM; Parker JE; Lamb DC; Kelly DE; Kelly SL Antimicrob Agents Chemother; 2012 Apr; 56(4):2099-107. PubMed ID: 22252802 [TBL] [Abstract][Full Text] [Related]
20. The R467K amino acid substitution in Candida albicans sterol 14alpha-demethylase causes drug resistance through reduced affinity. Lamb DC; Kelly DE; White TC; Kelly SL Antimicrob Agents Chemother; 2000 Jan; 44(1):63-7. PubMed ID: 10602724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]